Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5739-5742

  Zhao, Ying ^a   Agarwal, Veena R ^a   Mendelson, Carole R ^a   Simpson, Evan R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN; ESTROGEN RECEPTOR; PROSTAGLANDIN E2; PROTEIN KINASE C;

ADIPOSE TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ESTROGEN SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR GROWTH;

EID: 0030444771     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940410     Document Type: Article

References (24)

1. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342-355
2. Mahendroo MS, Mendelson CR, Simpson ER 1993 Tissue-specific and hormonally-controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem 268:19463-19470
3. arom: the promoter responsible for expression in adipose is different from that utilized in placenta. J Biol Chem 266:11276-11281
4. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR, Simpson ER 1991 Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol 5:2005-2013
5. O'Neill JS, Elton RA, Miller WR 1988 Aromatase activity in adipose tissue from breast quadrants: a link with tumor site. Brit Med J 296:741-743
6. Bulun SE, Price TM, Mahendroo MS, Aitken J, Simpson ER 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77:1622-1628
7. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ 1995 Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endo Metab 80:3052-3058
8. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER 1996 Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endo Metab in press:
9. Mendelson CR, Corbin CJ, Smith ME, Smith J, Simpson ER 1986 Growth factors suppress, and phorbol esters potentiate the action of dibutyryl cyclic AMP to stimulate aromatase activity of human adipose stromal cells. Endocrinology 118:968-973
10. Michael MD, Kilgore MW, Morohashi K-I, Simpson ER 1994 Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem 270:13561-13466
11. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299
12. Agarwal VR, Bulun SE, Simpson ER 1995 Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR. Mol Cell Probes 9:453-464
13. Ackerman GE, MacDonald PC, Gudelsky G, Mendelson CR, Simpson ER 1981 Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives. Endocrinology 109:2084-2088
14. Mendelson CR, Smith ME, Cleland WH, Simpson ER 1984 Regulation of aromatase activity of cultured adipose stromal cells by catecholamines and adrenocorticotropin. Mol Cell Endocrinol 37:61-72
15. Robertson RP 1995 Molecular regulation of prostaglandin biosynthesis. TEM 6:293-297
16. Miller WL, Weeks JR, Lauderdale JW 1975 Biological activities of 17-phenyl-18, 19, 20-trinor prostaglandins. Prostaglandins 9:9-18
17. Lippmann W 1974 Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxy-prostaglandin analogues: 15-hydroxy-16, 16-dimelhyl-9-oxoprost-5, 13-dienoric acids. Prostaglandins 7:231-246
18. 2 as a renal vasodilator and renin secretagogue. J Pharmacol Exp Ther 216:24-27
19. Evans CT, Corbin CJ, Saunders CT, Merrill JC, Simpson ER, Mendelson CR 1987 Regulation of estrogen biosynthesis in human adipose stromal cells: effects of dibutyryl cyclic AMP, epidermal growth factor, and phorbol esters on the synthesis of aromatase cytochrome P-450. J Biol Chem 262:6914-6920
20. Rolland PH, Martin PM, Jacquemier J, Rolland A, Toga M 1980 Suggesting that as elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64:1061-1070
21. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer 72:1412-1419
22. Mitchell MD, Cleland WH, Smith ME, Simpson ER, Mendelson CR 1983 Inhibition of prostaglandin biosynthesis in human adipose tissue by glucocorticosteroids. J Clin Endocrinol Metab 57:771-776
23. Carroll KK 1981 Neutral fats and cancer. Cancer Res 41:3695-3699
24. Harris RE, Nauboodim KK, Farrar WB 1996 Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology 1:203-205